Physician profile
Andrew Johnson
NPI 1821402736
$5,784.73
in general payments reported to CMS, 2019-2025
9 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,144 · 2020: $412 · 2021: $440 · 2022: $154 · 2023: $202 · 2024: $2,323 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,113 · Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,112.63 |
| Food and Beverage | $522.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Team 1, LLC | $2,323.23 | 2024 | |
| Sportstek Medical, INC | $2,144.00 | 2019 | |
| Stryker Corporation | $644.14 | 2020-2021 | |
| Smith+Nephew, INC. | $315.61 | 2020-2025 | Healicoil, Bioinductive Implant With Arthroscopic Delivery System - Medium, Novostitch |
| Boston Scientific Corporation | $229.12 | 2021-2023 | Avvigo Guidance System |
| Zimmer Biomet Holdings, INC. | $47.27 | 2022 | |
| Djo, LLC | $45.79 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.22 | 2023 | Trintellix |
| Nuvasive, INC. | $13.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.